The global sleep apnea diagnostic and therapeutic devices market will reach US$6,437.6 billion by 2019 from US$3,805.3 billion in 2012, according to a new report by Transparency Market Research. The report titled “Sleep Apnea Diagnostic and Therapeutic Devices Market (Actigraphy, Polysomnography (PSG) systems, Positive Airway Pressure (PAP) Devices, Oral Appliances and Others) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019” predicts a 7.8% compound annual growth rate from 2013 to 2019.
Within the diagnostic devices category, the actigraphy segment holds the highest market share followed by the segment of respiratory polygraphs. Furthermore, within the therapeutic devices category, the oral appliances segment and the positive airway pressure devices segment will grow robustly during the forecast period. Low adoption rate of technology inhibits the growth of the global sleep apnea diagnostic and therapeutic devices market.
Geographically, the global sleep apnea diagnostic and therapeutic devices market is categorized into Asia Pacific, Europe, North America and Rest of the World. This market is led by Europe and North America, with a collective market share exceeding 60%. Rising awareness and the presence of technologically advanced sleep laboratories fuel the sleep apnea diagnostic and therapeutic devices market in Europe and North America.
Insufficient healthcare infrastructure and lack of awareness about sleep apnea hamper the growth of the market in Asia Pacific and RoW.